Fractyl Health (GUTS) Revenue & Revenue Breakdown
Fractyl Health Revenue Highlights
Latest Revenue (Y)
$120.00K
Fractyl Health Revenue by Period
Fractyl Health Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $120.00K | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2019-12-31 | - | - |
Fractyl Health generated $120.00K in revenue during NA 2023, up 100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Fractyl Health Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-06-30 | - | 100.00% |
| 2025-03-31 | - | -100.00% |
| 2024-12-31 | $3.00K | -78.57% |
| 2024-09-30 | $14.00K | -67.44% |
| 2024-06-30 | $43.00K | 30.30% |
| 2024-03-31 | $33.00K | 371.43% |
| 2023-12-31 | $7.00K | -80.56% |
| 2023-09-30 | $36.00K | -50.00% |
| 2023-06-30 | $72.00K | 1340.00% |
| 2023-03-31 | $5.00K | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2022-09-30 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2021-09-30 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2020-09-30 | - | - |
Fractyl Health generated - in revenue during Q2 2025, up 100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Fractyl Health Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| DTIL | Precision BioSciences | $68.70M | $13.00K |
| STRO | Sutro Biopharma | $62.04M | $9.69M |
| MGX | Metagenomi | $44.76M | $8.66M |
| ARTV | Artiva Biotherapeutics | $33.49M | - |
| ADVM | Adverum Bio | $1.00M | - |
| ATYR | aTyr Pharma | $353.00K | $190.00K |
| GUTS | Fractyl Health | $120.00K | - |
| ALXO | ALX Oncology | - | - |
| RPTX | Repare Therapeutics | - | - |
| QNCX | Quince Therapeutics | - | - |
| BMEA | Biomea Fusion | - | - |